Konopleva M - Search Results

1

CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.

Koschmieder S, D'Alò F, Radomska H, Schöneich C, Chang JS, Konopleva M, Kobayashi S, Levantini E, Suh N, Di Ruscio A, Voso MT, Watt JC, Santhanam R, Sargin B, Kantarjian H, Andreeff M, Sporn MB, Perrotti D, Berdel WE, Müller-Tidow C, Serve H, Tenen DG. Koschmieder S, et al. Among authors: konopleva m. Blood. 2007 Nov 15;110(10):3695-705. doi: 10.1182/blood-2006-11-058941. Epub 2007 Aug 1. Blood. 2007. PMID: 17671235 Free PMC article. Clinical Trial.

2

Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.

Konopleva M, Estrov Z, Zhao S, Andreeff M, Mehta K. Konopleva M, et al. J Immunol. 1998 Nov 1;161(9):4702-8. J Immunol. 1998. PMID: 9794400

3

Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities.

Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, Kornblau SM, Dong J, Kliche KO, Jiang S, Snodgrass HR, Estey EH, Andreeff M. Konopleva M, et al. Blood. 1999 Mar 1;93(5):1668-76. Blood. 1999. PMID: 10029596 Free article.

4

Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.

Konopleva M, Tari AM, Estrov Z, Harris D, Xie Z, Zhao S, López-Berestein G, Andreeff M. Konopleva M, et al. Blood. 2000 Jun 15;95(12):3929-38. Blood. 2000. PMID: 10845930 Free article.

5

CD38 in hematopoietic malignancies.

Konopleva M, Rissling I, Andreeff M. Konopleva M, et al. Chem Immunol. 2000;75:189-206. doi: 10.1159/000058769. Chem Immunol. 2000. PMID: 10851785 Review. No abstract available.

6

Apoptosis regulating proteins as targets of therapy for haematological malignancies.

Kornblau SM, Konopleva M, Andreeff M. Kornblau SM, et al. Among authors: konopleva m. Expert Opin Investig Drugs. 1999 Dec;8(12):2027-2057. doi: 10.1517/13543784.8.12.2027. Expert Opin Investig Drugs. 1999. PMID: 11139839

7

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E, Andreeff M. Milella M, et al. Among authors: konopleva m. J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.

8

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Konopleva M, Tsao T, Ruvolo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May WS, Sporn MB, Andreeff M. Konopleva M, et al. Blood. 2002 Jan 1;99(1):326-35. doi: 10.1182/blood.v99.1.326. Blood. 2002. PMID: 11756188 Free article.

9

Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.

Milella M, Estrov Z, Kornblau SM, Carter BZ, Konopleva M, Tari A, Schober WD, Harris D, Leysath CE, Lopez-Berestein G, Huang Z, Andreeff M. Milella M, et al. Among authors: konopleva m. Blood. 2002 May 1;99(9):3461-4. doi: 10.1182/blood.v99.9.3461. Blood. 2002. PMID: 11964319 Free article.

10

Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies.

Konopleva M, Andreeff M. Konopleva M, et al. Curr Opin Hematol. 2002 Jul;9(4):294-302. doi: 10.1097/00062752-200207000-00006. Curr Opin Hematol. 2002. PMID: 12042703 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

715 results

Search Page

Filters